Illuco IDS 1100 Dermatoscope

Description

New Zealand has one of the highest rates of skin cancer globally, particularly melanoma, due to intense UV exposure and a predominantly fair-skinned population. This places significant responsibility on general practitioners and dermatology professionals to perform accurate, efficient dermoscopic examinations in both urban and rural settings.

IDS-1100 Hybrid Dermatoscope

The IDS-1100 is a high-performance hybrid dermatoscope designed to meet the demands of modern skin cancer screening. It combines cross-polarized and parallel-polarized light for versatile lesion analysis, eliminating the need for contact or immersion fluid in many cases.

 Key Features:

• 10x magnification with a wide 22 mm field of view
• 32 LEDs for bright, optimized illumination
• Cross & parallel polarization for layered skin structure visualization
• Blue light indicator for active polarization mode
• Three brightness levels for adaptable lighting
• Small contact plates (6 mm, 8 mm) for hard-to-reach areas
• Smartphone & camera compatibility for clinical documentation
• Magnetic contact plate mechanism for easy detachment
• Auto shut-off after 5 minutes of inactivity

Strategic Implications

• Enables efficient lesion screening without immersion fluid, ideal for high-throughput clinics and mobile health units.
• Supports early melanoma detection, reducing specialist referrals and improving patient outcomes.
• Enhances workflow efficiency and infection control, aligning with New Zealand’s goals in preventive care and digital health integration.